NuVasive Reports Third Quarter 2016 Financial Results

Go back to NuVasive Reports Third Quarter 2016 Financial Results

Jefferies Reiterates Buy on NuVasive (NUVA) Following 3Q Report

October 26, 2016 8:34 AM EDT

Jefferies reiterated a Buy rating and $72.00 price target on NuVasive (NASDAQ: NUVA) following the company's 3Q earnings report. For the year, the company is now guiding to $952mn in sales (down from $962mn). Components of this include the US capital stocking issue of... More

NuVasive (NUVA) Reports In-Line Q3 EPS, Trims FY Revenue Guidance

October 25, 2016 5:02 PM EDT

NuVasive (NASDAQ: NUVA) reported Q3 EPS of $0.40, in-line with the analyst estimate of $0.40. Revenue for the quarter came in at $239.6 million versus the consensus estimate of $243.52 million.

GUIDANCE:

NuVasive sees 2016 EPS of $1.64, versus the consensus of $1.65. NuVasive sees 2016 revenue of $954 million,... More